Gilead Sciences (GILD) Reports Encouraging Topline Data from Sofosbuvir + RBV Phase 3

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. TGT
2. EL
3. SPY
4. WMT
5. ROST
6. ADI
7. BILL
8. MRK
9. MRNA
10. TJX

Go back to Gilead Sciences (GILD) Reports Encouraging Topline Data from Sofosbuvir + RBV Phase 3
Gilead Sciences (NASDAQ: GILD) Delayed: 143.44 -4.16 (2.82%)
Previous Close $147.60    52 Week High $108.63 
Open $146.69    52 Week Low $71.39 
Day High $146.82    P/E 79.25 
Day Low $143.19    EPS $1.81 
Volume 7,167,581